← Back to headlines
Dianthus Therapeutics Reports Clinical Progress Despite Widening Financial Losses
The biotechnology firm achieved several positive clinical trial milestones for its gene therapy candidates, even as overall corporate expenses continue to outpace revenue.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Next Wins Appeal to Overturn £30 Million Equal Pay Ruling
35m ago
UEFA to Honor Nepal Flood Victims With Minute of Silence Before Champions League Matches
40m ago
Grindr Agrees to £26 Million Settlement Over Alleged Sharing of Users’ HIV Data
42m ago
Dangote Refinery Launches $1.6 Billion IPO in Nigeria
1h ago